<style>
.w-richtext p,.w-richtext li,.w-richtext td{font-size:18px;line-height:1.65}
.w-richtext h2{font-size:26px;line-height:1.35}
.w-richtext h3{font-size:22px;line-height:1.35}
.w-richtext ul{list-style-type:disc;padding-left:24px;margin:12px 0}
.w-richtext ul li{margin-bottom:8px;line-height:1.65}
.w-richtext .ac-action-plan{background:linear-gradient(135deg,#fffcf4 0%,#fff8ed 100%);border-left:5px solid #9a6841;border-radius:12px;padding:28px 24px;margin:32px 0;box-shadow:0 2px 12px rgba(0,0,0,0.06)}
.article-header-section .article-container{max-width:1080px !important;margin:0 auto !important;padding:0 20px !important}
.article-header-section .article-hero-image{display:block;width:100%;max-width:660px;margin:0}
.article-header-section .article-title{display:block !important;font-family:Georgia,serif;font-size:32px;line-height:1.25;font-weight:700;color:#313743;margin:20px 0 12px 0;text-align:left;max-width:660px}
@media (max-width:767px){.article-header-section .article-title{font-size:26px}.article-header-section .article-hero-image{max-width:100%}}
.ac-article-cta{margin-top:40px;text-align:center}
.ac-article-cta .ac-cta-lead{font-family:Georgia,serif;font-size:17px;color:#555;margin:0 0 16px 0;line-height:1.5}
.ac-article-cta a.ac-nav-cta{display:inline-flex;align-items:center;gap:10px;padding:10px 14px 10px 20px;background:#313743;color:#fff;border:1.5px solid #14D4CD;border-radius:82px;font-family:Inter,sans-serif;font-size:14px;font-weight:600;letter-spacing:0.3px;text-decoration:none;transition:transform 0.15s ease,box-shadow 0.15s ease}
.ac-article-cta a.ac-nav-cta:hover{transform:translateY(-1px);box-shadow:0 6px 18px rgba(20,212,205,0.25)}
.ac-article-cta .ac-nav-cta-arrow{width:28px;height:28px;background:#14D4CD;border-radius:50%;display:inline-flex;align-items:center;justify-content:center;flex-shrink:0}
.ac-article-cta .ac-nav-cta-arrow svg{width:14px;height:14px}
</style>
<p class="publish-date" style="font-size:13px; color:#999; margin-bottom:16px;">Published: June 1, 2026 · Last updated: June 1, 2026</p>
<div class="ac-glance" style="background-color: #ffffff; padding: 20px; border: 2px solid #b0bec5; border-radius: 8px; margin: 20px 0;"><strong>This week's brief at a glance:</strong><ul style="margin: 12px 0; padding-left: 24px;"><li style="margin-bottom:6px;">NIH National Institute on Aging research has confirmed that nicotinamide supplementation in aging mice produced some metabolic and physical-function improvements, but did not extend lifespan (NIH NIA, 2024)</li><li style="margin-bottom:6px;">Across roughly two dozen published human clinical trials, NR has reliably raised blood NAD+ levels, but the downstream clinical effects (strength, cognition, blood pressure) have been small and inconsistent (NIH NIA, 2024)</li><li style="margin-bottom:6px;">No NMN or NR product is approved by the FDA for any disease, and major US clinical guidance bodies continue to recommend against routine use outside of formal clinical trials (NIH NCCIH, 2024)</li></ul></div>
<p>NMN and NR have been marketed as the supplements that "reverse cellular aging." The pitch is appealing: NAD+ declines with age, NAD+ runs your mitochondria, raise NAD+ and you turn the clock back. The pitch is also several jumps ahead of the actual data.</p>
<p>The newer studies have not vindicated the most aggressive claims. They have softened them. Here is what the trials actually show, what they do not, and how a careful consumer might think about it.</p>
<h3>What NMN and NR Actually Are</h3>
<p><strong>Two NAD+ Precursors:</strong> Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) are both vitamin B3 derivatives the body converts to NAD+, a coenzyme cells use for energy metabolism and DNA repair. Older adults have lower tissue NAD+ than younger adults, and the longevity hypothesis is that raising it back should turn back at least some functional aging (<a href="https://www.nia.nih.gov/news/nicotinamide-supplement-aging-mice-shows-some-health-improvements-not-increased-longevity" target="_blank" rel="noopener">NIH NIA, 2024</a>).</p>
<p>The hypothesis is reasonable. The clinical question is whether oral supplementation actually delivers, and at what magnitude. That is the question the trials are answering, slowly.</p>
<h3>What the Animal Studies Showed</h3>
<p><strong>Better Metabolism, Not Longer Lives:</strong> Aging mice fed NAM (a closely related precursor) over more than a year showed better glucose handling, less fatty liver, and better physical performance than expected for their age. Important detail: lifespan was not extended. The intervention improved how the mice aged without giving them more years.</p>
<p>This pattern, "healthspan" improvement without lifespan gain, is the more honest framing for what these precursors might offer. It is not nothing. It is also not the headline a supplement label wants to put on a bottle.</p>
<h3>What the Human Trials Have Found</h3>
<p><strong>The Numbers Are Real, the Effects Are Modest:</strong> NR has been tested in over two dozen published human trials, mostly in adults, at doses up to 1,000 to 2,000 mg per day for up to several months. The clearest finding is that NR raises blood and tissue NAD+ levels reliably and safely. Downstream effects on the things people actually care about (muscle insulin sensitivity, blood pressure, cognition, walking distance in peripheral artery disease) have been small, mixed, and often missed primary endpoints.</p>
<p>A 2022 trial in older women showed a modest but real improvement in muscle insulin sensitivity with NMN. A 2024 NICE trial in peripheral artery disease showed a clinically meaningful walking improvement among compliant users. Trials in cognitive impairment and long-COVID have shown more equivocal results.</p>
<h3>Why the Marketing Outruns the Data</h3>
<p><strong>Where the Hype Comes From:</strong> Most of the dramatic "reverse aging" claims trace back to animal studies, in vitro work, or biomarker shifts (blood NAD+, sirtuin activation) rather than the outcomes patients live with. When research news bulletins are translated to consumer marketing, "improved one biomarker in mice" becomes "reverses cellular aging in humans" in a way that does not survive scrutiny (<a href="https://www.nccih.nih.gov/health/providers/digest/myth-busting-popular-natural-products-marketed-for-disease-prevention-and-wellness-science" target="_blank" rel="noopener">NIH NCCIH, 2024</a>).</p>
<p>Add a $40 to $80 monthly price tag and a confident podcast appearance and you have a product that sells well regardless of what the trials say.</p>
<h3>Safety, Quality, and How to Think About Trying It</h3>
<p><strong>Short-Term Safety Looks Okay; Long-Term Is Unknown:</strong> In trials lasting weeks to several months, both NR and NMN have looked well-tolerated at typical doses. There are some theoretical concerns about whether sustained NAD+ elevation could accelerate growth of subclinical cancers, since NAD+ also fuels tumor metabolism. The data is too thin to call that a real risk, but it is the most cited reason NIH-funded researchers urge caution rather than enthusiasm (<a href="https://www.nccih.nih.gov/health/tips/tips-natural-products-used-for-common-agingrelated-conditions" target="_blank" rel="noopener">NIH NCCIH, 2024</a>).</p>
<p>If you decide to try one, NR has the deeper trial record. Stick to USP-verified or NSF-certified brands, and skip the "longevity stacks" combining NMN with five other unverified compounds. Watch for clinical-trial enrollment opportunities; the data is far more useful inside a structured study than from a personal experiment.</p>
<h3>The Boring Levers Still Outperform</h3>
<p><strong>What Actually Has Lifespan Evidence:</strong> Regular exercise (especially zone 2 cardio plus strength training), a Mediterranean-style diet, 7 to 8 hours of sleep, and not smoking remain the only interventions with population-level lifespan and healthspan data. NMN and NR may have a future role. They are not a substitute for the basics.</p>
<div class="ac-action-plan" style="background: linear-gradient(135deg, #fffcf4 0%, #fff8ed 100%); border-left: 5px solid #9A6841; border-radius: 12px; padding: 28px 24px; margin: 32px 0; box-shadow: 0 2px 12px rgba(0,0,0,0.06);"><div style="display: flex; align-items: center; gap: 10px; margin-bottom: 20px;"><svg width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="#9A6841" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M9 5H7a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V7a2 2 0 00-2-2h-2"/><rect x="9" y="3" width="6" height="4" rx="1"/><path d="M9 14l2 2 4-4"/></svg><span style="font-family: Georgia, serif; font-size: 22px; font-weight: 700; color: #313743;">Your Coach's Recommendations</span></div><div style="display: flex; gap: 14px; margin-bottom: 16px; align-items: flex-start;"><div style="min-width: 36px; width: 36px; height: 36px; background: #9A6841; border-radius: 50%; display: flex; align-items: center; justify-content: center; color: #fff; font-weight: 700; font-size: 16px; flex-shrink: 0;">1</div><div><div style="font-weight: 700; color: #313743; font-size: 15px; margin-bottom: 2px;">Treat NMN and NR as Experimental, Not Established</div><div style="color: #6b7280; font-size: 13.5px; line-height: 1.5;">The evidence base is improving but does not yet support claims of reversing aging or extending lifespan. Trial it only with informed expectations and after the basics (exercise, sleep, nutrition) are already in place.</div></div></div><div style="display: flex; gap: 14px; margin-bottom: 16px; align-items: flex-start;"><div style="min-width: 36px; width: 36px; height: 36px; background: #9A6841; border-radius: 50%; display: flex; align-items: center; justify-content: center; color: #fff; font-weight: 700; font-size: 16px; flex-shrink: 0;">2</div><div><div style="font-weight: 700; color: #313743; font-size: 15px; margin-bottom: 2px;">If You Try It, Pick NR With Third-Party Verification</div><div style="color: #6b7280; font-size: 13.5px; line-height: 1.5;">NR has more published human trial data than NMN. Choose USP-verified or NSF-certified. Skip multi-ingredient longevity stacks combining unproven compounds at unclear doses.</div></div></div><div style="display: flex; gap: 14px; margin-bottom: 20px; align-items: flex-start;"><div style="min-width: 36px; width: 36px; height: 36px; background: #9A6841; border-radius: 50%; display: flex; align-items: center; justify-content: center; color: #fff; font-weight: 700; font-size: 16px; flex-shrink: 0;">3</div><div><div style="font-weight: 700; color: #313743; font-size: 15px; margin-bottom: 2px;">Tell Your Doctor; Consider Joining a Trial</div><div style="color: #6b7280; font-size: 13.5px; line-height: 1.5;">If you have a relevant condition (mild cognitive impairment, peripheral artery disease, certain metabolic syndromes), enrolling in a registered clinical trial of NR or NMN produces better information than a personal n=1 experiment.</div></div></div><div style="border-top: 1px solid #e5ddd4; margin: 16px 0;"></div><div style="display: flex; justify-content: center; align-items: center; gap: 10px; flex-wrap: wrap;"><button onclick="acPrintPlan()" style="background: none; border: 1px solid #d3cabe; border-radius: 8px; padding: 10px 16px; font-size: 13px; color: #6b7280; cursor: pointer; display: flex; align-items: center; gap: 6px;"><svg width="14" height="14" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><polyline points="6 9 6 2 18 2 18 9"/><path d="M6 18H4a2 2 0 01-2-2v-5a2 2 0 012-2h16a2 2 0 012 2v5a2 2 0 01-2 2h-2"/><rect x="6" y="14" width="12" height="8"/></svg>Print</button></div></div>
<div style="margin-top: 32px; padding-top: 0;">
<div style="width: 60px; height: 2px; background: linear-gradient(90deg, #9A6841, #be7b4c); border-radius: 2px; margin-bottom: 20px;"></div>
<p style="font-family: Georgia, serif; font-size: 16px; font-style: italic; color: #777; margin: 0 0 6px 0; letter-spacing: 0.3px; padding-left: 38px;">To your health,</p>
<div style="display: flex; align-items: center; gap: 4px; margin-bottom: 4px;">
<img src="https://cdn.prod.website-files.com/69be130d412f9c2c202307ef/69c539b9526b266e2cba5521_ageless-coach-logo-black.png" alt="AC" style="width: 34px; height: 34px; object-fit: contain;">
<p style="font-family: Georgia, serif; font-size: 22px; font-weight: 700; color: #313743; margin: 0; letter-spacing: 0.5px;">Ageless Coach</p>
</div>
<p style="font-family: -apple-system, BlinkMacSystemFont, Segoe UI, sans-serif; font-size: 11px; font-weight: 600; color: #be7b4c; letter-spacing: 2px; text-transform: uppercase; margin: 0 0 0 28px;">Age Strong. Live Long.</p>
</div>
<div style="margin-top: 28px; padding-top: 20px; border-top: 1px solid #e5e7eb; text-align: center;">
<p style="font-family: -apple-system, BlinkMacSystemFont, Segoe UI, sans-serif; font-size: 13px; font-weight: 700; color: #6b7280; letter-spacing: 2px; text-transform: uppercase; margin: 0 0 16px 0;">Trusted Sources Behind This Article</p>
<div style="display: flex; justify-content: center; gap: 10px; flex-wrap: wrap;">
<a href="https://www.nia.nih.gov/news/nicotinamide-supplement-aging-mice-shows-some-health-improvements-not-increased-longevity" target="_blank" rel="noopener" style="display: inline-block; background: #fff; border: 1.5px solid #9A6841; color: #9A6841; padding: 8px 20px; border-radius: 20px; font-size: 14px; font-weight: 600; letter-spacing: 0.3px; text-decoration: none; transition: background 0.2s ease, color 0.2s ease;">NIH NIA</a>
<a href="https://www.nccih.nih.gov/health/providers/digest/myth-busting-popular-natural-products-marketed-for-disease-prevention-and-wellness-science" target="_blank" rel="noopener" style="display: inline-block; background: #fff; border: 1.5px solid #9A6841; color: #9A6841; padding: 8px 20px; border-radius: 20px; font-size: 14px; font-weight: 600; letter-spacing: 0.3px; text-decoration: none; transition: background 0.2s ease, color 0.2s ease;">NIH NCCIH</a>
<a href="https://www.nccih.nih.gov/health/tips/tips-natural-products-used-for-common-agingrelated-conditions" target="_blank" rel="noopener" style="display: inline-block; background: #fff; border: 1.5px solid #9A6841; color: #9A6841; padding: 8px 20px; border-radius: 20px; font-size: 14px; font-weight: 600; letter-spacing: 0.3px; text-decoration: none; transition: background 0.2s ease, color 0.2s ease;">NIH NCCIH</a>
</div>
</div>
<p style="font-size: 12px; color: #999; margin-top: 40px; line-height: 1.5;"><em>This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reading this article does not create a provider-patient relationship. Always consult your physician or qualified healthcare provider before making changes to your diet, exercise, or health routine. Ageless Coach is not liable for any actions taken based on this information.</em></p>
<div class="ac-faq" style="margin-top:40px; border-top:1px solid #e5e7eb; padding-top:32px;">
<h2 style="font-family:Georgia,serif; font-size:20px; font-weight:700; color:#313743; margin:0 0 20px 0;">Frequently Asked Questions</h2>
<details style="border:1px solid #e5e7eb; border-radius:8px; margin-bottom:10px; overflow:hidden;">
<summary style="padding:14px 18px; font-weight:600; font-size:15px; color:#313743; cursor:pointer; list-style:none; display:flex; justify-content:space-between; align-items:center;">
Is NMN safer than NR?
<svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="#9A6841" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><polyline points="6 9 12 15 18 9"/></svg>
</summary>
<div style="padding:0 18px 16px; font-size:18px; color:#555; line-height:1.65;">Both look acceptably safe in short-term trials. NR has more published human data, so if you want the better-characterized option, NR is it. NMN's regulatory status has been more contested in the US.</div>
</details>
<details style="border:1px solid #e5e7eb; border-radius:8px; margin-bottom:10px; overflow:hidden;">
<summary style="padding:14px 18px; font-weight:600; font-size:15px; color:#313743; cursor:pointer; list-style:none; display:flex; justify-content:space-between; align-items:center;">
Do these supplements actually reverse aging?
<svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="#9A6841" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><polyline points="6 9 12 15 18 9"/></svg>
</summary>
<div style="padding:0 18px 16px; font-size:18px; color:#555; line-height:1.65;">No, not in the sense most marketing implies. They raise NAD+ levels and may modestly improve certain age-related functions. Reversing aging (more years of life, organs returning to a younger state) is not what the trials show.</div>
</details>
<details style="border:1px solid #e5e7eb; border-radius:8px; margin-bottom:10px; overflow:hidden;">
<summary style="padding:14px 18px; font-weight:600; font-size:15px; color:#313743; cursor:pointer; list-style:none; display:flex; justify-content:space-between; align-items:center;">
What dose was used in the trials?
<svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="#9A6841" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><polyline points="6 9 12 15 18 9"/></svg>
</summary>
<div style="padding:0 18px 16px; font-size:18px; color:#555; line-height:1.65;">NR trials commonly used 250 mg to 1,000 mg per day for several months. A few trials went up to 2,000 mg per day for shorter durations. NMN trials typically used 250 mg to 900 mg per day. None of these doses are FDA-approved for any indication.</div>
</details>
<details style="border:1px solid #e5e7eb; border-radius:8px; margin-bottom:10px; overflow:hidden;">
<summary style="padding:14px 18px; font-weight:600; font-size:15px; color:#313743; cursor:pointer; list-style:none; display:flex; justify-content:space-between; align-items:center;">
Can NMN or NR cause cancer?
<svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="#9A6841" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><polyline points="6 9 12 15 18 9"/></svg>
</summary>
<div style="padding:0 18px 16px; font-size:18px; color:#555; line-height:1.65;">There is a theoretical concern that elevated NAD+ could fuel growth of existing cancer cells, since some tumors use NAD+ heavily. Human evidence is not available either way. Anyone with a cancer history or active surveillance should discuss this with their oncologist before supplementing.</div>
</details>
<details style="border:1px solid #e5e7eb; border-radius:8px; margin-bottom:10px; overflow:hidden;">
<summary style="padding:14px 18px; font-weight:600; font-size:15px; color:#313743; cursor:pointer; list-style:none; display:flex; justify-content:space-between; align-items:center;">
Is taking plain niacin or B3 just as good?
<svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="#9A6841" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><polyline points="6 9 12 15 18 9"/></svg>
</summary>
<div style="padding:0 18px 16px; font-size:18px; color:#555; line-height:1.65;">Not exactly. Plain niacin can raise NAD+ but commonly causes the well-known flushing reaction at NAD+-raising doses, and high-dose nicotinic acid has its own cardiovascular profile. NMN and NR aim to skip the flush. Whether they translate into clinical benefit is still the open question.</div>
</details>
<details style="border:1px solid #e5e7eb; border-radius:8px; margin-bottom:10px; overflow:hidden;">
<summary style="padding:14px 18px; font-weight:600; font-size:15px; color:#313743; cursor:pointer; list-style:none; display:flex; justify-content:space-between; align-items:center;">
Should I expect to feel different on these?
<svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="#9A6841" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><polyline points="6 9 12 15 18 9"/></svg>
</summary>
<div style="padding:0 18px 16px; font-size:18px; color:#555; line-height:1.65;">Most users do not report dramatic subjective changes. Some describe slight energy or recovery shifts, which can also be placebo. If you are looking for a noticeable felt effect, sleep and training improvements deliver more reliably.</div>
</details>
<details style="border:1px solid #e5e7eb; border-radius:8px; margin-bottom:10px; overflow:hidden;">
<summary style="padding:14px 18px; font-weight:600; font-size:15px; color:#313743; cursor:pointer; list-style:none; display:flex; justify-content:space-between; align-items:center;">
What should the next round of studies focus on?
<svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="#9A6841" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><polyline points="6 9 12 15 18 9"/></svg>
</summary>
<div style="padding:0 18px 16px; font-size:18px; color:#555; line-height:1.65;">Longer-duration trials (12+ months), clinically meaningful endpoints (strength, walking, cognition, fall risk), and head-to-head comparisons with established lifestyle interventions. Those are the studies that would actually tell us whether NMN and NR earn the price tag.</div>
</details>
</div>
<div class="ac-article-cta">
<p class="ac-cta-lead">Want one verified-science article like this every week?</p>
<a href="/newsletter" class="ac-nav-cta">
Get Better Health, Weekly
<span class="ac-nav-cta-arrow">
<svg viewBox="0 0 18 18" fill="none" xmlns="http://www.w3.org/2000/svg" aria-hidden="true"><path d="M4.24 13.59L12.73 5.11" stroke="#0D1B2A" stroke-width="1.8"/><path d="M4.95 4.4H13.44V12.89" stroke="#0D1B2A" stroke-width="1.8"/></svg>
</span>
</a>
</div>
Get Better Health, Weekly